跳转至内容
Merck
CN

T9197

Tissue Inhibitor of Metalloproteinase-3 人

>95% (SDS-PAGE), recombinant, expressed in BHK cells, buffered aqueous solution

别名:

TIMP-3

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352200
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

recombinant

expressed in BHK cells

assay

>95% (SDS-PAGE)

form

buffered aqueous solution

mol wt

glycosylated form ~30 kDa, ~23 kDa (unglycosylated form)

UniProt accession no.

shipped in

wet ice

storage temp.

−20°C

Gene Information

human ... TIMP3(7078)

Biochem/physiol Actions

The TIMPs are endogenous inhibitors of the matrix metalloproteinases (MMPs). TIMP-3 inhibits ADAM-17 (TACE) at nanomolar concentrations and also inhibits other metalloproteinases (sheddases) that mediate the shedding of soluble receptors and other proteins from the surface of cells.

Physical form

Supplied in acitve form, in 10 mM MES, pH 5.0, 100 mM sodium chloride, 0.02% Brij-35 and 50% glycerol.

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

M L Sulis et al.
Leukemia, 25(10), 1564-1569 (2011-06-01)
Oncogenic mutations in NOTCH1 are present in over 50% of T-cell lymphoblastic leukemias (T-ALLs). Activation of NOTCH1 requires a double proteolytic processing in the extracellular region of the receptor (S2) and in the transmembrane domain (S3). Currently, anti-NOTCH1 therapies based

相关内容

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持